1. Home
  2. XERS vs ASIC Comparison

XERS vs ASIC Comparison

Compare XERS & ASIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XERS
  • ASIC
  • Stock Information
  • Founded
  • XERS 2005
  • ASIC 2018
  • Country
  • XERS United States
  • ASIC United States
  • Employees
  • XERS N/A
  • ASIC N/A
  • Industry
  • XERS Biotechnology: Pharmaceutical Preparations
  • ASIC Property-Casualty Insurers
  • Sector
  • XERS Health Care
  • ASIC Finance
  • Exchange
  • XERS Nasdaq
  • ASIC Nasdaq
  • Market Cap
  • XERS 1.3B
  • ASIC 1.1B
  • IPO Year
  • XERS 2018
  • ASIC 2025
  • Fundamental
  • Price
  • XERS $7.36
  • ASIC $20.49
  • Analyst Decision
  • XERS Strong Buy
  • ASIC Strong Buy
  • Analyst Count
  • XERS 7
  • ASIC 4
  • Target Price
  • XERS $8.00
  • ASIC $27.00
  • AVG Volume (30 Days)
  • XERS 1.9M
  • ASIC 74.7K
  • Earning Date
  • XERS 11-07-2025
  • ASIC 08-11-2025
  • Dividend Yield
  • XERS N/A
  • ASIC N/A
  • EPS Growth
  • XERS N/A
  • ASIC N/A
  • EPS
  • XERS N/A
  • ASIC 0.15
  • Revenue
  • XERS $246,025,000.00
  • ASIC $378,302,000.00
  • Revenue This Year
  • XERS $43.89
  • ASIC $16.14
  • Revenue Next Year
  • XERS $20.40
  • ASIC $47.06
  • P/E Ratio
  • XERS N/A
  • ASIC $135.21
  • Revenue Growth
  • XERS 35.62
  • ASIC 42.48
  • 52 Week Low
  • XERS $2.69
  • ASIC $18.50
  • 52 Week High
  • XERS $8.03
  • ASIC $25.30
  • Technical
  • Relative Strength Index (RSI)
  • XERS 51.35
  • ASIC N/A
  • Support Level
  • XERS $7.56
  • ASIC N/A
  • Resistance Level
  • XERS $7.89
  • ASIC N/A
  • Average True Range (ATR)
  • XERS 0.24
  • ASIC 0.00
  • MACD
  • XERS -0.14
  • ASIC 0.00
  • Stochastic Oscillator
  • XERS 2.90
  • ASIC 0.00

About XERS Xeris Biopharma Holdings Inc.

Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).

About ASIC Ategrity Specialty Insurance Company Holdings Common Stock

Ategrity Specialty Insurance Co Holdings Formerly Ategrity Specialty Holdings LLC is a specialty insurance company dedicated to providing excess and surplus products to small to medium-sized businesses across the United States. It offers property and casualty insurance solutions tailored to meet the needs of SMBs. The company focuses on are Real Estate, Hospitality, Construction, and Retail.

Share on Social Networks: